Dan Gebremedhin, MD, MBAMedicare 101 for Digital Health Part 2: How digital health companies can gain traction in MedicareFlare Capital Partners’ Gwendolyn Lee & Dr. Dan Gebremedhin highlight digital health startups taking advantage of Medicare and key…Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAMedicare 101 for Digital Health Part 1: What is Medicare and how did it get this way?An intro to Medicare, and how digital health companies can impact the nation’s biggest payer.Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAWhy we invested in Eden HealthFlare Capital Partner Dan Gebremedhin explains what led the venture capital firm to invest in New York-based Eden Health and lead its…Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBABeyond Covid-19: 5 opportunities for startups to reshape the future healthcare landscapeOriginally Published in MedCity News on 7/22/2020Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAInnovation in substance use disorder treatment: 5 Keys to ImpactFlare Capital Partners reviews the current landscape of substance use disorder treatment and highlights some early-stage tech companies…Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAHow to improve adoption of genetic testing into provider workflow?Flare Capital Partners offers an overview of sequencing options, opportunities for integration into clinical workflow and the companies…Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBABehavioral health innovation two years later: Why is adoption taking so long?An in-depth look at the market forces shaping the development and adoption (or lack thereof) of behavioral health technology.Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAThe ”Dirty Secret” of the FFS SystemOriginally published under the title: The Patient Population Failed Most by the Fee for Service System on 10/31/2018 by Gibson ConsultantsDec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAWe need social workers — not Facebook — to better understand our patients’ healthOriginally Published in CNBC on 4/10/2018Dec 29, 2020Dec 29, 2020
Dan Gebremedhin, MD, MBAMedication Adherence Tech: A dynamic and crowded market, but where are the winners in the space?Originally published in MobiHealth News on 8/27/2017Dec 29, 2020Dec 29, 2020